French oncologist person

Named in 1 report across 1 story - 20 Aug

The stories

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

43 outlets1 report names French oncologist19 Aug – 27 Aug

Organisations in the same coverage

Merck1 Moderna1

Who keeps naming them

Anadolu Agency (AA)1